Medscape Psychiatry Editorial Board

Editorial Board — Medscape Psychiatry & Mental Health

Board Members

Christoph U. Correll, MD
- Hofstra North Shore Long Island School of Medicine
  Hempstead, New York
  The Zucker Hillside Hospital
  Glen Oaks, New York
Eric Hollander, MD
- Albert Einstein College of Medicine
  Spectrum Neuroscience and Treatment Institute
  New York, NY
Jeffrey A. Lieberman, MD
- Columbia University
  New York State Psychiatric Institute/Columbia University Medical Center
  New York, New York

Drew Ramsey, MD
- Columbia University
  New York, New York
Stephen M. Strakowski, MD
- Professor and Chair
  Dell Medical School
  University of Texas

Board Member Details

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Glen Oaks, New York

Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, partner, employee, advisor, consultant, or trustee for: Alkermes; Allergan; Angelini; Boehringer-Ingelheim; Gedeor; Richter; Gerson Lehrman Group; Indivior; IntraCellular Therapies; Janssen/J&J; LB Pharma; Lundbeck; MedAvante-ProPhase; Medscape; Merck; Neurocrine; Noven; Otsuka; Pfizer; Recordati; Rovi; Servier; Sumitomo; Dainippon; Sunovion; Supernus; Takeda; Teva
Provided expert testimony for: Bristol-Myers Squibb; Janssen; Otsuka
Serve(d) as a speaker for: Allergan; Angelini; Gedeon Richter; Janssen/J&J; Lundbeck; Merck; Otsuka; Pfizer; Recordati; Servier; Sunovion
Received research grant from: Janssen; Takeda
Received income in an amount equal to or greater than $250 from: Alkermes; Allergan; Angelini; Boehringer-Ingelheim; Gedeor Richeter; Gerson Lehrman Group; Indivior; IntraCellular Therapies; Janssen/J&J; LB Pharma; Lundbeck; MedAvante-ProPhase; Medscape; Merck; Neurocrine; Noven; Otsuka; Pfizer; Recordati; Rovi; Servier; Sunitomo; Dainippon; Sunovion; Supernus; Takeda; Teva
Serve(d) on the Data Safety Monitoring Board for: Boehringer-Ingelheim; Lundbeck; Rovi; Supernus; Teva
Receives royalties for: UpToDate
Shareholder for: LB Pharma

[ Back to Top ]

Eric Hollander, MD

Professor of Psychiatry & Behavioral Sciences, Psychiatry Research Institute of Montefiore Einstein; Director, Spectrum Neuroscience and Treatment Institute, New York, New York

Eric Hollander, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Sunovion
Received research grant from: Roche
Received income in an amount equal to or greater than $250 from: American Psychiatric Publishing

[ Back to Top ]

Jeffrey A. Lieberman, MD

Chairman, Department of Psychiatry, Columbia University; Director, Department of Psychiatry, New York State Psychiatric Institute, New York, New York

Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board for: Intracellular Therapies; Pierre Fabre
Received research grant from: Alkermes; Boehringer-Ingelheim; Eli Lilly/DeNovo; Taisho; Teva
Has a patent for: Repligen
Received royalty payments for: SHRINKS: The Untold Story of Psychiatry

[ Back to Top ]

Drew Ramsey, MD

Assistant Clinical Professor, Department of Psychiatry, Columbia University, New York, New York

Drew Ramsey, MD, has disclosed the following relevant financial relationships:
Have a 5% or greater equity interest in: Eat to Beat Depression eCourse
Author: Eat Complete; The Happiness Diet; 50 Shades of Kale

[ Back to Top ]

Stephen M. Strakowski, MD

Professor and Chair; Associate Vice President, Regional Mental Health, Department of Psychiatry, Dell Medical School, University of Texas, Austin

Stephen M. Strakowski, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Sunovion (DSMB chair)
Received research grant to institution from: Janssen; Otsuka (both paid to Dr Strakowski's institution)
Received income in an amount equal to or greater than $250 from: Sunovion

[ Back to Top ]